Intervention Review

Antipsychotic medication for challenging behaviour in people with learning disability

  1. Jane Brylewski2,
  2. Lorna Duggan1,*

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 19 JUL 2004

Assessed as up-to-date: 30 NOV 2003

DOI: 10.1002/14651858.CD000377.pub2

How to Cite

Brylewski J, Duggan L. Antipsychotic medication for challenging behaviour in people with learning disability. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD000377. DOI: 10.1002/14651858.CD000377.pub2.

Author Information

  1. 1

    Care Principles Ltd, Newmarket, Suffolk, UK

  2. 2

    Oxford, UK

*Lorna Duggan, Care Principles Ltd, Oaks Lodge, Fordham Road, Newmarket, Suffolk, CB8 7XN, UK. lornaduggan@yahoo.co.uk. Lorna.Duggan@careprinciples.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 JUL 2004

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Paul Willner, The neurobiology of aggression: implications for the pharmacotherapy of aggressive challenging behaviour by people with intellectual disabilities, Journal of Intellectual Disability Research, 2014, 58, 5
  2. 2
    Andrew Jahoda, Paul Willner, Carol Pert, Kenneth M.A. MacMahon, Challenging Behavior, 2013,

    CrossRef

  3. 3
    Gerd Lehmkuhl, Judith Sinzig, Tanja Sappok, Albert Diefenbacher, Psychische Erkrankungen, 2012,

    CrossRef

  4. 4
    Nora D.B. Friedman, Karen J. Shedlack, Assessment and Management of Patients with Intellectual Disabilities by Psychiatric Consultants, Psychosomatics, 2011, 52, 3, 210

    CrossRef

  5. 5
    C. Paton, A. Flynn, A. Shingleton-Smith, S. McIntyre, S. Bhaumik, J. Rasmussen, S. Hardy, T. Barnes, Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services, Journal of Intellectual Disability Research, 2011, 55, 7
  6. 6
    Karen McKenzie, Providing services in the United Kingdom to people with an intellectual disability who present behaviour which challenges: A review of the literature, Research in Developmental Disabilities, 2011, 32, 2, 395

    CrossRef

  7. 7
    Johnny L Matson, Jonathan Wilkins, Antipsychotic drugs for aggression in intellectual disability, The Lancet, 2008, 371, 9606, 9

    CrossRef

  8. 8
    The Maudsley 2005-2006 Prescribing Guidelines, 2005,

    CrossRef

  9. 9
    Alex Thomson, Stefanos Maltezos, Elena Paliokosta, Kiriakos Xenitidis, Risperidone for attention deficit hyperactivity disorder in people with intellectual disabilities, The Cochrane Library,
  10. 10
    Alex Thomson, Stefanos Maltezos, Elena Paliokosta, Kiriakos Xenitidis, Risperidone for attention-deficit hyperactivity disorder in people with intellectual disabilities, The Cochrane Library,
  11. 11
    Heidre Bezuidenhout, Charles Shey Wiysonge, Judith M Bentley, Risperidone for disruptive behaviour disorders in children with intellectual disabilities, The Cochrane Library,